OBJECTIVE: We investigated the expression of thymidine phosphorylase (TP) in bladder carcinomas and assessed its prognostic significance in superficial bladder cancer samples. PATIENTS AND METHODS: We studied 142 primary bladder cancer samples immunohistochemically for nuclear thymidine phosphorylase (TPN), cytoplasmic (TPC) and stromal (TPSTR) expression. We correlated them with standard clinicopathological features (grade, stage, concurrent in situ, multiplicity, primary or recurrent status), as well with recurrence and progression. We examined also the relationship between TP and tumor microvessel density. RESULTS: The level of all types of TP correlated well with stage, while grade correlated well only with TPSTR and the presence of carcinoma in situ only with TPN. Patients with low levels of TPN had a longer tumor free interval, during a 38.6 months mean follow up time. Regarding the association between TP count and microvessel density we found the strongest association with TPSTR (p=0.003), a borderline statistical significance with TPC (p=0.049) and no relationship with TPN (p=0.072). CONCLUSIONS: We suggest that the assessment of TPN might be useful for predicting recurrence in superficial bladder cancer. We propose also that TP may stimulate angiogenesis.
OBJECTIVE: We investigated the expression of thymidine phosphorylase (TP) in bladder carcinomas and assessed its prognostic significance in superficial bladder cancer samples. PATIENTS AND METHODS: We studied 142 primary bladder cancer samples immunohistochemically for nuclear thymidine phosphorylase (TPN), cytoplasmic (TPC) and stromal (TPSTR) expression. We correlated them with standard clinicopathological features (grade, stage, concurrent in situ, multiplicity, primary or recurrent status), as well with recurrence and progression. We examined also the relationship between TP and tumor microvessel density. RESULTS: The level of all types of TP correlated well with stage, while grade correlated well only with TPSTR and the presence of carcinoma in situ only with TPN. Patients with low levels of TPN had a longer tumor free interval, during a 38.6 months mean follow up time. Regarding the association between TP count and microvessel density we found the strongest association with TPSTR (p=0.003), a borderline statistical significance with TPC (p=0.049) and no relationship with TPN (p=0.072). CONCLUSIONS: We suggest that the assessment of TPN might be useful for predicting recurrence in superficial bladder cancer. We propose also that TP may stimulate angiogenesis.
Authors: M Haraguchi; K Miyadera; K Uemura; T Sumizawa; T Furukawa; K Yamada; S Akiyama; Y Yamada Journal: Nature Date: 1994-03-17 Impact factor: 49.962
Authors: F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin Journal: Nature Date: 1989-04-13 Impact factor: 49.962
Authors: Y Imazano; Y Takebayashi; K Nishiyama; S Akiba; K Miyadera; Y Yamada; S Akiyama; Y Ohi Journal: J Clin Oncol Date: 1997-07 Impact factor: 44.544
Authors: J Arima; Y Imazono; Y Takebayashi; K Nishiyama; T Shirahama; S Akiba; T Furukawa; S Akiyama; Y Ohi Journal: Cancer Date: 2000-03-01 Impact factor: 6.860
Authors: Y Takebayashi; S Natsugoe; M Baba; S Akiba; T Fukumoto; K Miyadera; Y Yamada; S Takao; S Akiyama; T Aikou Journal: Cancer Date: 1999-01-15 Impact factor: 6.860
Authors: T S O'Brien; S B Fox; A J Dickinson; H Turley; M Westwood; A Moghaddam; K C Gatter; R Bicknell; A L Harris Journal: Cancer Res Date: 1996-10-15 Impact factor: 12.701
Authors: S Takao; Y Takebayashi; X Che; H Shinchi; S Natsugoe; K Miyadera; Y Yamada; S Akiyama; T Aikou Journal: Clin Cancer Res Date: 1998-07 Impact factor: 12.531
Authors: J Scott Brockenbrough; Janice K Morihara; Stephen E Hawes; Joshua E Stern; Janet S Rasey; Linda W Wiens; Qinghua Feng; Hubert Vesselle Journal: J Histochem Cytochem Date: 2009-08-03 Impact factor: 2.479